Verification of Compendial Methods
|
|
- Thomasina Perry
- 6 years ago
- Views:
Transcription
1 Verification of Compendial Methods ภญ.ดร ดร.ส ภาณ ดวงธ รปร ชา ส าน กยาและว ตถ เสพต ด กรมว ทยาศาสตร การแพทย 7 ม ถ นายน
2 Scopes : Overview Asean Analytical Validation Guidelines Verification of Compendial Methods EDQM AOAC USP ACTD BDN? 2
3 From ASEAN Analytical Validation Guidelines Type of Analytical Procedure Identification Testing for Impurities Assay Performance Characteristic Quantitative Limit test dissolution content/potency Accuracy Precision Repeatability Interm.Precision LOD LOQ Linearity Range 3
4 : The ability to measure accurately and specificity the analyte in the presence of components that may be expected to be present in the matrix The degree of interference : Active ingredients Excipients Impurities Degradation Products etc 4
5 : Identification Tests Demonstrate ability to select between compounds of closely related structure confirm positive and negative results Assay Demonstrate that the results are unaffected by spiked impurities or excipients Impurities Spike the drug product/substance with impurities and demonstrate appropriate accuracy and precision 5
6 : Impurities are available Demonstrate that the assay is unaffected by the present of spiked material (impurities and/or excipients) Impurities are not available Compare test results to a second wellcharacterized procedure For assay : compare the two result For Impurity Tests : compare purity profiles Peak Purity Test (e.g. PDA, MS) 6
7 Linearity: The ability of the method to elicit test results that are directly proportational to concentration within a given range Range: Interval between upper and lower levels of analyte demonstrated by the method Precision and accuracy expressed in the same units as the test results 7
8 Evaluation of Linearity Established across the range of the method Dilutions Separate weighings Evaluate by appropriate statistical methods (e.g.regression) include correlation coefficient, yintercept, slope, plot Minimum 5 concentrations 8
9 Determination of appropriate range Minimum specified range : assay : 80120% Impurity test : from QL to 120% spec Content unformity : 70130% test conc Dissolution testing : / 20% over specified range 9
10 Precision: The measure of the degree of agreement among test results when the method is applied repeatedly to multiple samplings of a homogeneous sample Expressed as %RSD for a statiscally significant number of samples 10
11 Precision: should be performed at 3 levels Repeatability Intermediate Precision Reproducibility 11
12 Precision: Repeatability Same operating conditions, short time interval Min of 9 determinations covering specified range of procedure (3 levels, 3 reps each) Min of 6 determinations at 100% test conc Intermediate Precision Withinlab variations Different days, analysts, equipment Reproducibility Precision between labs Collaborative studies 12
13 Accuracy: The closeness of test results to the true value obtained by the method established across the range 13
14 Accuracy: Drug Substance Analysis of reference material Compare results to a second, wellcharacterized method Drug Product Analysis of synthetic mixtures spiked with known quantities of components Compare results to a second, wellcharacterized method Determined concurrently with precision, linearlity and specificity 14
15 Accuracy: Impurities (Quantitation( Quantitation) Analysis of sample (Drug substances/drug product) spiked with known amounts of impurities Recommended Data Min of 9 determinations over a min of 3 conc levels covering the specified range (e.g. 3 conc/3 replicates each) Report as % recovery of known, added amount, or difference between the mean and true value, with confidence intervals 15
16 Detection Limit (LOD): Lowest concentration of analyte in a sample that can be detected (not necessarily quantitated) Limit test : above or below a certain level Expressed as concentration (%, ppb) Almost necessary not determine actual detection limit 16
17 Detection Limit (LOD): Visual (Noninstrumental methods) Signal to noise ratio (3:1 or 2:1 generally accepted) Detection limit may be based on the standard deviation of the response and slope: DL = (3.3)STD/S STD = standard deviation of the response S = slope of the calibration curve 17
18 Quantitation Limit (LOQ): Lowest concentration of analyte in a sample that can be determined with acceptable precision and accuracy under stated operational conditions Expressed as concentration of analyte accuracy precision 18
19 Quantitation Limit (LOQ): Visual (Noninstrumental methods) Signal to noise ratio (10:1 is typical) Quantitation limit may be based on the standard deviation of the response and slope: QL = (10)STD/S STD = standard deviation of the response S = slope of the calibration curve Both DL and QL are validated by analyzing a suitable number of samples. Method should be documented. 19
20 Verification of Compendial Methods EDQM AOAC USP ACTD 20
21 From EDQM : 1. Transfer of a Method A verification of suitability under conditions of use (=method transfer check) has to be done 1.1 Pharmacopoeial (compendial) method Active substance Identification: no formal validation required Testing for Impurities: no formal validation required Assay: no formal validation required 21
22 From EDQM : 1.1 Pharmacopoeial (compendial) method Medicinal product Identification: no formal validation required Testing for Impurities: specificity: no interference from excipients reporting threshold (at least the quant. limit) Assay: specificity accuracy: mainly recovery, min 1 det. precision (repeatability): around the target test conc. (min 2 independent det.) linearity at three measuring points in the range around the target value. 22
23 From AOAC : How to meet ISO requirements for Method Verification Activities needed for method verification are a subset of those for validation. 23
24 From AOAC : Performance Characteristics Included in a Validation Performance Characteristic Identification 1 Analyte at low conc quantitative 2 Analyte at low conc Limit test 3 Analyte at high conc quantitative 4 Analyte at high conc Limit test 5 Quanlitative 6 Accuracy No No No Precision No No No LOD No /No No No LOQ No No /No No No Ruggedness No No No No Linearity/ Range No No No No 24
25 From AOAC : How to meet ISO requirements for Method Verification Category1 : Confirmation of identity A method that ensures a material is what it purports to be or confirms the detection of the target analyte 25
26 Category1 : Identification Performance Characteristic Verification No If the lab s samples are identical to those in the standard method and if and differences in instrumentation do not impact specificity if the lab s sample differ from those in the standard method if differences between instruments could affect specificity Verification Activities NA Same as those required for validation The activity need only deal with the unique aspect s of the lab s samples or instrumentation 26
27 From AOAC : How to meet ISO requirements for Method Verification Category2 : Analyte at Low Concentration, Quantitative 27
28 Category2:Analyte at Low Concentration, Quantitative Performance Characteristic 1. Accuracy Verification Verification Activities If the concentration range for which the method is validated is narrow (<1 order of magnitude), analyze one reference material/standard/spike at one concentration level. Otherwise, demonstrate accuracy at each concentration level (low, middle, high) by anlyzing one reference material/standard/spike at each level. 28
29 Category2:Analyte at Low Concentration, Quantitative Performance Characteristic 2. Precision Verification Verification Activities Perform the repeatability test once. If the method covers a concentration range>1 order of magnitude, then the repeatability test must include low, middle and high concentrations. 29
30 Category2:Analyte at Low Concentration, Quantitative Performance Characteristic 3. Verification No/ Verification Activities 4. LOD Run a sample close to LOD 5. LOQ Run a sample close to LOQ 30
31 From AOAC : How to meet ISO requirements for Method Verification Category3 : Analyte is present above or below a specified, low concentration (Limit Test) 31
32 Category3 : Limit Test Performance Characteristic 1. Verification No/ Verification Activities 2. LOD Run a sample close to LOD 3. LOQ Run a sample close to LOQ 32
33 From AOAC : How to meet ISO requirements for Method Verification Category4 : Quantifying an analyte at high concentration 33
34 Category4 : Assay Performance Characteristic 1. Accuracy Verification Verification Activities If the concentration range for which the method is validated is narrow (<1 order of magnitude), analyze one reference material/standard/ spike at one concentration level. Otherwise, demonstrate accuracy at each concentration level (low, middle, high) by anlyzing one reference material/standard/spike at each level. 34
35 Category4 : Assay Performance Characteristic 2. Precision 3. Verification No/ Verification Activities Perform the repeatability test once. If the method covers a concentration range>1 order of magnitude, then the repeatability test must include low, middle and high concentrations. 35
36 From USP : Verification of Compendial Procedures <1226> 36
37 USP: Validation of Compendial Procedures <1225> Category II Performance Characteristic Category I (Assay) (Impurities) Quantitative Limit test Category III (dissolution) Category IV (Identification) Accuracy Precision LOD LOQ Linearity Range 37
38 Verification of Compendial Procedures<1226> Verification of Compendial Procedures. The purpose of this new general information chapter is to provide guidelines for verifying the suitability of a compendial procedure under actual conditions of use,, as stated in 21 CFR (a)(2). Because it is not necessary for users of compendial procedures to perform a complete validation, but rather, to confirm that the procedure works for their drug substance, excipient, or dosage form,, verification can be accomplished by assessing a subset of validation characteristics. This new chapter is considered an extension of the general information chapter Validation of Compendial Methods <1225>, and both chapters use similar terminology. Interested parties are encouraged to submit comments by July 15,
39 Verification of Compendial Procedures<1226> verifying the suitability of a compendial procedure under actual conditions of use But No Guidelines 39
40 Data Elements for Verification of Drug Substances and and Excipients* Technique Category (assay) Category II (impurities) Category III (dissolution) Category IV (identification) Quantitative Limit test HPLC/GC Precision Precision LOQ LOD Spectro photometric/ colorimetric Precision Precision LOQ LOD Titrimetric Precision Precision TLC LOQ LOD Gel Electro Phoresis LOQ LOD * Not official 40
41 Data Elements for Verification of Dosage Forms Technique Category I (assay) Category II (impurities) Category III (dissolution) Category IV (identification) Quantitative Limit test HPLC/GC Precision Linearity Range Precision LOQ LOD Precision Spectro photometric/ colorimetric Precision Linearity Range Precision LOQ LOD Precision Titrimetric Precision Linearity Range TLC Gel Electro phoresis * Not official Precision LOQ LOQ LOD LOD 41
42 Category I: Analytical procedures for quantitation of major components of drug substances or active ingredients (including preservatives) in finished dosage forms. Category II: Analytical procedures for determination of impurities in drug substances or degradation compounds in finished pharmaceutical products. These procedures include quantitative assays and limit tests. Category III: Analytical procedures for determination of performance characteristics (e.g., dissolution, drug release). Category IV: Identification procedures. 42
43 From ACTD P5 : Control of Finished Product 5.3 Validation of Analytical Procedure Verification of compendial method applicability Accuracy Precision 43
44 Comparison : Assay USP Precision Linearity Range EDQM Precision Linearity Accuracy AOAC Precision Accuracy 44
45 Recommendation (BDN): For Assay: Precision at 100 % (6 det.) Accuracy at 100% (3 det.) Linearity (5 points) 45
46 Comparison : Impurity (Quantitative) USP Precision LOQ EDQM LOQ AOAC Precision LOQ, LOD Accuracy 46
47 Recommendation (BDN): For Impurity (Quantitative) : LOQ Precision (6 det.) Accuracy (3 det.) 47
48 Comparison : Impurity (Limit tests) USP LOD EDQM LOQ (LOD?) AOAC LOQ, LOD 48
49 Recommendation (BDN): For Impurity (Limit tests) : LOD 49
50 Comparison : Identification USP EDQM No formal validation required AOAC 50
51 Verification documentation : The verification exercise must be planned, approved, and documented and a final report kept on file to demonstrate the lab can perform the method adequately. Verification documentation should be created that: Described the procedure to be verified Details the analytical performance characteristics to be evaluated Established acceptance criteria used to determine that the procedure perform suitably Justifies deviations from reference method 51
52 Thank You for Your Attention 52
á1225ñ VALIDATION OF COMPENDIAL PROCEDURES
1640 á1224ñ Transfer of Analytical Procedures / General Information USP 39 THE ANALYTICAL PROCEDURE The procedure should be written with sufficient detail and explicit instructions, so that a trained analyst
More informationVALIDATION OF ANALYTICAL PROCEDURES: METHODOLOGY *)
VALIDATION OF ANALYTICAL PROCEDURES: METHODOLOGY *) Guideline Title Validation of Analytical Procedures: Methodology Legislative basis Directive 75/318/EEC as amended Date of first adoption December 1996
More informationVICH Topic GL2 (Validation: Methodology) GUIDELINE ON VALIDATION OF ANALYTICAL PROCEDURES: METHODOLOGY
The European Agency for the Evaluation of Medicinal Products Veterinary Medicines Evaluation Unit CVMP/VICH/591/98-FINAL London, 10 December 1998 VICH Topic GL2 (Validation: Methodology) Step 7 Consensus
More informationValidation of Analytical Methods used for the Characterization, Physicochemical and Functional Analysis and of Biopharmaceuticals.
Validation of Analytical Methods used for the Characterization, Physicochemical and Functional Analysis and of Biopharmaceuticals. 1 Analytical Method Validation: 1..1 Philosophy: Method validation is
More informationTEMPLATE FOR AN EXAMPLE METHODS VALIDATION STANDARD OPERATING PROCEDURE (SOP)
APPENDIX II TEMPLATE FOR AN EXAMPLE METHODS VALIDATION STANDARD OPERATING PROCEDURE (SOP) SOP EXAMPLE TEMPLATE 1. PURPOSE 1.1 This procedure is intended to provide general guidelines for the validation
More informationICH Q2(R1) A Primer. cgmp. GxP PIC/S SOP ISO QA/QC LOD/LOQ. Validation of Analytical Methods API EP FDA OECD GCP
USP ICH Q2(R1) A Primer GxP cgmp PIC/S SOP ISO 17025 QA/QC LOD/LOQ API EP Validation of Analytical Methods FDA OECD GCP Validation of Analytical Methods Ludwig Huber Contents Preface...............................................
More informationUnderstanding the Characteristics and Establishing Acceptance Criteria for Analytical Methods Validation
Understanding the Characteristics and Establishing Acceptance Criteria for Analytical Methods Validation Ying Verdi IVT LAB WEEK EUROPE June 2017 Partners in Health Since 1919 Regulatory View of Method
More informationGUIDANCE NOTES ON ANALYTICAL METHOD VALIDATION
ON ANALYTICAL METHOD VALIDATION HSA September 2004 Reproduction prohibited for commercial purposes. Reproduction for internal use is authorised, provided the source is acknowledged. MQA Dir: DISK1\GUIDE-MQA-012A-004.doc
More informationAnalytical Procedures and Methods Validation for Drugs and Biologics
Final Guidance for Industry Analytical Procedures and Methods Validation for Drugs and Biologics Analytical procedures and Method Validation June 21, 2016 Lokesh Bhattacharyya Chief, LACBRP/DBSQC OCBQ/CBER/FDA
More informationImpurity Control in the European Pharmacopoeia
Impurity Control in the European Pharmacopoeia Training Session Zagreb, Croatia, 24-25 May, 2018 Dr Ulrich Rose Head of Division European Pharmacopoeia Department, EDQM Agenda Which impurities are controlled?
More informationCRITERIA FOR VALIDATION OF METHODS USED BY CHEMICAL LABORATORIES AND RELATED INDUSTRIES
Document No: SADCAS TR 17 Issue No: 1 CRITERIA FOR VALIDATION OF METHODS USED BY CHEMICAL LABORATORIES AND RELATED INDUSTRIES Prepared by: SADCAS Advisory Committee TLAP Approved by: SADCAS CEO Approval
More informationPerspectives on Method Validation: Importance of Adequate Method Validation
Perspectives on Method Validation: Importance of Adequate Method Validation Heather Bridwell, Vikas Dhingra, Daniel Peckman, Jennifer Roark and Thomas Lehman The appropriate validation of analytical methods
More informationMethod Development and Validation for Online UV-Dissolution Methods Using Fiber-Optic Technology
Technical Overview Method Development and Validation for Online UV-Dissolution Methods Using Fiber-Optic Technology Introduction Online fiber-optic and multicell UV-dissolution systems have become increasingly
More informationPhase Appropriate Method Validation
Phase Appropriate Method Validation Aryo Nikopour Irvine, California January 12, 2017 The Southern California Pharmaceutical Discussion Group (SCPDG) of AAPS OUTLINE What is Validation Guidelines Method
More informationThank You to United States Pharmacopeia for Their Sponsorship and Assistance
Use of Measurement Uncertainty in Testing a Drug Substance M.L. Jane Weitzel Quality Analysis Consultants mljweitzel@msn.com Eurachem/CITAC Workshop June 2011 Thank You to United States Pharmacopeia for
More information10. Validated Normal Phase HPLC Method for the Determination. Fulvestrant is primarily used in the treatment of hormone receptor
229 10. Validated Normal Phase HPLC Method for the Determination of Fulvestrant in Pharmaceutical Dosage Forms 10.1 Introduction Fulvestrant is primarily used in the treatment of hormone receptor positive
More informationValidation/Verification of Test Methods An FDA Perspective. Laure H. Kairawicz, Ph.D. Senior Scientist Expert Witness
Validation/Verification of Test Methods An FDA Perspective Laure H. Kairawicz, Ph.D. Senior Scientist Expert Witness FD & C Act Overview Definition of drugs What cgmps are Finished Pharmaceuticals cgmp
More informationA2LA. R231 Specific Requirements: Threat Agent Testing Laboratory Accreditation Program. December 6, 2017
Laboratory Page 1 of 17 Laboratory December 6, 2017 2017 by A2LA All rights reserved. No part of this document may be reproduced in any form or by any means without the prior written permission of A2LA.
More information3. Equipment Cleaning Validation for Active Pharmaceutical Ingredients (APIs) 8. Process Validation for Active Pharmaceutical Ingredients (API)
Title: Good Working Practice Validation Requirements Practice Number: 06 Prepared by: Date: Supersedes: Checked by: Date: Date Issued: Approved by: Date: Review Date: Topics: 1. Biological Test Methods
More informationRevision of 30 April 2013 draft, 4 November 2013
GUIDANCE DOCUMENT FOR SINGLE LABORATORY VALIDATION OF QUANTITATIVE ANALYTICAL METHODS USED IN SUPPORT OF PRE- AND POST-REGISTRATION DATA REQUIREMENTS FOR PLANT PROTECTION AND BIOCIDAL PRODUCTS INTRODUCTION
More informationValidation & Transfer of Methods for
Validation & Transfer of Methods for Course option 1: Pharmaceutical Analysis, or Course option 2: Biopharmaceutical Analysis TRAINING COURSE This course will provide you with the requisite scientific
More informationFusion Analytical Method Validation
Fusion QbD Software System Fusion Analytical Method Validation The Only Software That Has It All! 100% aligned with FDA/ICH Quality by Design (QbD) guidances! Can be used for LC and Non-LC methods (e.g.
More informationReview on Analytical Method Development and Validation.
Research and Reviews: Journal of Pharmaceutical Analysis Review on Analytical Method Development and Validation. Rajendra Patil 1*, Tushar Deshmukh 1, Vijay Patil 1, and Kishanchand Khandelwal 2.. 1 TVES
More information9/2/2014. USP Monograph Modernization. Todays topics. USP basic. Todays topics. - USP basic. - USP publications. - USP monograph modernization
USP Monograph Modernization Procedure Review and Development Donald Min 2 USP basic Since USP's founding in 1820, our operations have grown exponentially: from 11 volunteers collaborating from their respective
More informationTECHNICAL GUIDANCE FOR THE VALIDATION OF METHODS USED BY CHEMICAL LABORATORIES IN THE FOOD, WATER AND RELATED INDUSTRIES
TECHNICAL GUIDANCE FOR THE VALIDATION OF METHODS USED BY CHEMICAL LABORATORIES IN THE FOOD, WATER AND RELATED INDUSTRIES Approved By: Chief Executive Officer: Ron Josias Senior Manager: Christinah Leballo
More informationVerification of Method XXXXXX
Reviewed By: Date: Technical Supervisor Reviewed By: Date: General Supervisor Reviewed By: Date: Quality Assurance Coordinator Approved By: Date: Director Page 1 of 11 Table of Contents Purpose and Principle:...
More informationBioanalytical method validation: An updated review
Review Article www.phmethods.org Bioanalytical method validation: An updated review Abstract The development of sound bioanalytical method(s) is of paramount importance during the process of drug discovery
More informationRegulatory Expectations for Method Transfers: Health Canada's Perspective CMC Strategy Forum Methods on the move January 23, 2017
Regulatory Expectations for Method Transfers: Health Canada's Perspective CMC Strategy Forum Methods on the move January 23, 2017 Hugo Hamel, Senior Biologist/Evaluator, BGTD Overview of the Post-NOC Changes
More informationApplication note. Guideline for validation of analytical methods using Cedex Bio, Cedex Bio HT, and Cedex HiRes Analyzers.
Application note Guideline for validation of analytical methods using Cedex Bio, Cedex Bio HT, and Cedex HiRes Analyzers April 216 Doerthe Druhmann, Sabrina Schuette, Dr. Dirk Ponsel Pharma Biotech, Penzberg,
More informationAnalytical Methods Development and Validation
Understanding and Implementing Efficient Analytical Methods Development and Validation Jay Breaux, Kevin Jones, and Pierre Boulas Analytical methods development and validation play important roles in the
More informationA Simple Rapid and Sensitive Method Development for Quantification of Quetiapine Fumarate in Bulk and Dosage Forms Using RP-HPLC
Human Journals Research Article February 2018 Vol.:11, Issue:3 All rights are reserved by Priyanka Teepoju et al. A Simple Rapid and Sensitive Method Development for Quantification of Quetiapine Fumarate
More informationAgreed by VICH Steering Committee January Adoption by CVMP 12 February Date for coming into effect January 2016
12 February 2015 EMA/CVMP/VICH/463202/2009 Committee for Medicinal Products for Veterinary Use (CVMP) VICH topic GL49: Studies to evaluate the metabolism and residues kinetics of veterinary drugs in human
More informationClick to edit Master text styles
Quantitative Second estimation level of Anti-degradants in tyre components Presented by Tirthankar Bhandary 1 Degradation of polymer BACKGROUND Reaction of anti-degradant Possibility of resonance of radical
More informationTechnical requirements to Good Manufacturing Practice in metered dose inhalers production and development (2. part) Extractable - Leachable
Technical requirements to Good Manufacturing Practice in metered dose inhalers production and development (2. part) Extractable - Leachable Dr. Gyula Körtvélyessy UNIDO Honorary Secretary General of the
More information1225 VALIDATION OF lytical performance characteristics that should be considered COMPENDIAL PROCEDURES
USP 36 General Information / 1225 Validation of Compendial Procedures 1 formance characteristics of the procedure meet the requirements for the intended analytical applications. Typical ana- 1225 VALIDATION
More informationMETHOD VALIDATION TECHNIQUES PREPARED FOR ENAO ASSESSOR CALIBRATION COURSE OCTOBER/NOVEMBER 2012
METHOD VALIDATION PREPARED FOR ENAO ASSESSOR CALIBRATION COURSE TECHNIQUES OCTOBER/NOVEMBER 2012 Prepared by for ENAO Assessor Calibration B SCOPE Introduction House Rules Central Tendency Statistics Population
More informationVICH Topic GL49. at step 4 GUIDELINES FOR THE VALIDATION OF ANALYTICAL METHODS USED IN RESIDUE DEPLETION STUDIES
European Medicines Agency Veterinary Medicines and Inspections London, 14 December 2009 Doc. Ref. EMEA/CVMP/VICH/463202/2009-CONSULTATION VICH Topic GL49 at step 4 GUIDELINES FOR THE VALIDATION OF ANALYTICAL
More informationEuropean Pharmacopoeia Reference Standards A Lodi, Head of the Laboratory Department, EDQM, Council of Europe
European Pharmacopoeia Reference Standards A Lodi, Head of the Laboratory Department, EDQM, Council of Europe Content Ph. Eur. Reference Standards General notices, terms and definitions Key attributes
More informationWe are IntechOpen, the first native scientific publisher of Open Access books. International authors and editors. Our authors are among the TOP 1%
We are IntechOpen, the first native scientific publisher of Open Access books 3,350 108,000 1.7 M Open access books available International authors and editors Downloads Our authors are among the 151 Countries
More informationFunctionality. Normal Operation
Application Note Automating EPA Method 200.8 using the SDXHPLD High Performance Liquid Dilution System Jim Maximovich, Teledyne CETAC Technologies, Omaha, NE, USA, Jim.Maximovich@Teledyne.com The SDX HPLD
More informationChemical Aspects of Stability Evaluation
Chemical Aspects of Stability Evaluation 8 steps to generating stability data which speaks for itself Alan Doughty Chief Chemist Pty Ltd Aim of a stability trial Obtain data which allows a definitive conclusion
More informationAn Alternative Approach to Quantitative Methods: Limit test for Analysis of Deeming Analytes in Electronic Cigarettes
An Alternative Approach to Quantitative Methods: Limit test for Analysis of Deeming Analytes in Electronic Cigarettes Carl Adams, Salem Chouchane and Darius Grissom www.eurofinslancasterlabs.com Questions
More informationLifecycle Management Concepts to analytical Procedures: A compendial perspective. Horacio Pappa, Ph.D. Director - General Chapters U.S.
Lifecycle Management Concepts to analytical Procedures: A compendial perspective Horacio Pappa, Ph.D. Director - General Chapters U.S. Pharmacopeia USP Definitions Validation of Compendial Procedures
More informationAnalytical Method Transfer Program. Richard B. Nguyen. Associate Scientific Liaison, Chemical Medicines, USP
Analytical Method Transfer Program Richard B. Nguyen. Associate Scientific Liaison, Chemical Medicines, USP Outline Requirements for an AMT Program Develop Your AMT Program Qualify Your AMT Program On-going
More informationBIOEQUIVALENCE TRIAL INFORMATION FORM (Medicines and Allied Substances Act [No. 3] of 2013 Part V Section 39)
ZAMRA BTIF BIOEQUIVALENCE TRIAL INFORMATION FORM (Medicines and Allied Substances Act [No. 3] of 2013 Part V Section 39) The Guidelines on Bioequivalence Studies to be consulted in completing this form.
More informationUnderstanding and accounting for product
Understanding and Modeling Product and Process Variation Variation understanding and modeling is a core component of modern drug development. Understanding and accounting for product and process variation
More informationAdditional guidance on: TNsG on Data Requirements, Part A, Chapter 2, Point 4. Analytical Methods for Detection and Identification.
Additional guidance on: TNsG on Data Requirements, Part A, Chapter 2, Point 4 Analytical Methods for Detection and Identification and Part B, Chapter 2, Point 4 Methods of Identification and Analysis These
More informationDevelopment and validation of stability indicating RP-HPLC method for the estimation of Daclatasvir in bulk and formulation
Available online at www.scholarsresearchlibrary.com Scholars Research Library Der Pharmacia Lettre, 2016, 8 (15):107-113 (http://scholarsresearchlibrary.com/archive.html) ISSN 0975-5071 USA CODEN: DPLEB4
More informationAutomating HPLC and GC Analytical Method Validation Fusion AE Software Program White Paper
Automating HPLC and GC Analytical Method Validation Fusion AE Software Program White Paper Varian, Inc. 2700 Mitchell Drive Walnut Creek, California 94598, USA www.varianinc.com Introduction Chromatographic
More informationProposed New USP General Chapter: The Analytical Procedure Lifecycle 1220
Page 1 of 9 STIMULI TO THE REVISION PROCESS Stimuli articles do not necessarily reflect the policies of the USPC or the USP Council of Experts Proposed New USP General Chapter: The Analytical Procedure
More informationAnalytical Procedures and Methods Validation for Drugs and Biologics
Analytical Procedures and Methods Validation for Drugs and Biologics Lucinda (Cindy) Buhse, Ph. D. Acting Director, Office of Testing and Research Office of Pharmaceutical Science CDER, FDA CHPA Quality
More informationFusion Analytical Method Validation
Fusion QbD Software Platform Fusion Analytical Method Validation The Only Software That Has It All! 100% aligned with FDA/ICH Quality by Design (QbD) guidances! Can be used for LC and Non-LC methods (e.g.
More informationDEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD FOR ASSAY DETERMINATION OF ISOSULFAN BLUE BY LIQUID CHROMATOGRAPHY
DEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD FOR ASSAY DETERMINATION OF ISOSULFAN BLUE BY LIQUID CHROMATOGRAPHY KISHORKUMAR L.MULE 1 Department of Chemistry, Shri Jagdish Prasad Jhabarmal Tibrewala
More informationAutomating HPLC and GC Analytical Method Validation Fusion AE Software Program White Paper
Automating HPLC and GC Analytical Method Validation Fusion AE Software Program White Paper S-Matrix Corporation 1594 Myrtle Avenue Eureka, CA 95501, USA www.smatrix.com Introduction Chromatographic analytical
More informationGeneral concepts in the Ph. Eur.: theory and rationale
General concepts in the Ph. Eur.: theory and rationale General Notices, General Chapters and General Monographs Cathie Vielle Head of European Pharmacopoeia Department The structure of the Ph. Eur. 2 General
More informationCASE-STUDY- VALIDATION of PCR based methodology. Beata Surmacz-Cordle Senior Analytical Development Scientist
CASE-STUDY- VALIDATION of PCR based methodology Beata Surmacz-Cordle Senior Analytical Development Scientist UK RMP Pluripotent Stem Cell Platform Validation Workshop 2 nd June 2016 RT-qPCR assay for detection
More informationGOOD LABORATORY PRACTICE Agilent Cary 8454 UV-Visible Spectroscopy System
GOOD LABORATORY PRACTICE Agilent Cary 8454 UV-Visible Spectroscopy System Introduction The objective of good laboratory practice (GLP) is to obtain accurate and precise results, using a measurement system
More informationSTABILITY TESTING OF NEW DRUG SUBSTANCES AND PRODUCTS
INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED TRIPARTITE GUIDELINE STABILITY TESTING OF NEW DRUG SUBSTANCES AND PRODUCTS
More informationJAI RESEARCH FOUNDATION A Global Contract Research Organisation
JAI RESEARCH FOUNDATION A Global Contract Research Organisation METHOD FOR THE DETERMINATION OF MANCOZEB RESIDUES IN TEST MEDIA FOR ECOTOX STUDIES Author : S.Y. Pandey and P.K. Dubey Jai Research Foundation
More informationMedicines Control Authority Of Zimbabwe
Medicines Control Authority Of Zimbabwe BIOEQUIVALENCE APPLICATION FORM Form: EVF03 This application form is designed to facilitate information exchange between the Applicant and the MCAZ for bioequivalence
More informationRegulatory Perspective on Analytical Method Validation During Product Development
Regulatory Perspective on Analytical Method Validation During Product Development CASSS CMC Strategy Forum 2018 Jacek Cieslak CDER/OPQ/OBP FDA Disclaimer This presentation reflects the views of the author
More informationCOMMITTEE FOR PROPRIETARY MEDICINAL PRODUCTS (CPMP)
The European Agency for the Evaluation of Medicinal Products Evaluation of Medicines for Human Use London, 17 December 2003 CPMP/QWP/122/02, rev 1 COMMITTEE FOR PROPRIETARY MEDICINAL PRODUCTS (CPMP) GUIDELINE
More informationAnalytical Method of Limit Test for Hexachlorobenzene. in Picloram TC and Method Validation Data*
Analytical Method of Limit Test for Hexachlorobenzene in Picloram TC and Method Validation Data* Test Method (ABCTM-2010-01-07) 1. Apparatus Electronic Balance GC/MS System with NCI Ultrasonic Water Bath
More informationRADIOPHARMACY GMP QC HPLC VALIDATION
RADIOPHARMACY GMP QC HPLC VALIDATION AERTS JoëlPhD, PARIS-DIDEROT, ULG GIACOMELLI Fabrice PhD, ULG HUBERT Philippe PhD, ULG IANNIELLO Jimmy Pharm, ULG MARINI Roland PhD, ULG 17th symposium of the Belgian
More informationAnalytical Validation within the Pharmaceutical Environment
3 1 Analytical Validation within the Pharmaceutical Environment Joachim Ermer Validation is, of course, a basic requirement to ensure quality and reliability of the results for all analytical applications
More information11 th INTERNATIONAL SYMPOSIUM ON PHARMACEUTICAL REFERENCE STANDARDS. Siriphorn Laomanacharoen 21 December 2012
11 th INTERNATIONAL SYMPOSIUM ON PHARMACEUTICAL REFERENCE STANDARDS Siriphorn Laomanacharoen 21 December 2012 11 th INTERNATIONAL SYMPOSIUM ON PHARMACEUTICAL REFERENCE STANDARDS Organised by European Directorate
More informationBIOEQUIVALENCE TRIAL INFORMATION
PRESENTATION OF BIOEQUIVALENCE TRIAL INFORMATION BIOEQUIVALENCE TRIAL INFORMATION GENERAL INSTRUCTIONS: Please review all the instructions thoroughly and carefully prior to completing the Bioequivalence
More informationExtending Beyond Use Dating for Compounded Preparations Webinar Q&A
Stability Studies 1. If potency over time studies are not acceptable to extend BUD, then why is it offered? Potency point-in-time studies only indicate the potency of a compounded preparation at that specific
More informationExtending Beyond Use Dating for Compounded Preparations Webinar Q&A
Stability Studies 1. If potency over time studies are not acceptable to extend BUD, then why is it offered? Potency point-in-time studies only indicate the potency of a compounded preparation at that specific
More informationWhy Do I Test, What Do I Test & When Do I Test It? Ross Caputo, PhD Chief Technical Officer Eagle Analytical Services
Why Do I Test, What Do I Test & When Do I Test It? Ross Caputo, PhD Chief Technical Officer Eagle Analytical Services Disclosures I, Ross Caputo, declare no conflicts of interest, real or apparent, and
More informationvalidation report for TaqMan Roundup Ready Quantification Kit
validation report for TaqMan Roundup Ready Quantification Kit Life Technologies offers a breadth of products DNA RNA protein cell culture instruments For Research Use Only. Not intended for any animal
More informationINTERNATIONAL JOURNAL OF RESEARCH IN PHARMACY AND LIFE SCIENCES
B. Venkateswara Reddy et al IJRPLS, 2014, 2(2): 236-247 Review Article Available online at www.pharmaresearchlibrary.com/ijrpls ISSN: 2321-5038 INTERNATIONAL JOURNAL OF RESEARCH IN PHARMACY AND LIFE SCIENCES
More informationCLSI C60: Assay Validation & Post-Validation Monitoring
CLSI C60: Assay Validation & Post-Validation Monitoring Ross J. Molinaro, MT(ASCP), PhD, DABCC, FACB Medical Director Core Laboratory, Emory University Hospital Midtown Emory Clinical Translational Research
More informationValidation of a concentration assay using Biacore C
GE Healthcare Application Note 48 Biacore systems Validation of a concentration assay using Biacore C Guideline for development of a GxP - compliant concentration assay Support for informed decision-making
More informationCorrelation coefficient
Application Note The SDXHPLD High Performance Liquid Dilution System yields smaller %RSD, therefore it provides cost savings and more profitability when utilized with Precious Metals Extracts Jim Maximovich,
More informationValidation, Verification and Transfer of Analytical Methods (Understanding and implementing guidelines from FDA/EMA, USP and ICH)
Validation, Verification and Transfer of Analytical Methods (Understanding and implementing guidelines from FDA/EMA, USP and ICH) *** LIMITED TIME OFFER: FREE $100 AMAZON GIFT CARD! *** REGISTER TODAY!
More informationAvailable online at ScienceDirect. Procedia Engineering 132 (2015 )
Available online at www.sciencedirect.com ScienceDirect Procedia Engineering 132 (2015 ) 811 815 The Manufacturing Engineering Society International Conference, MESIC 2015 Metrological Regulations for
More informationExamples of regulatory expectations for analytical characterization and testing
Examples of regulatory expectations for analytical characterization and testing AT Europe 2016, 18 March 2016 Vicki Venizelos Quality RA B.V. Leiden, the Netherlands Overview What are the regulatory expectations?
More informationPharmacopoeial Reference Standards
Pharmacopoeial Reference Standards Industry view point Antony Raj Gomes Head- Quality Management 1 Presentation Overview Indian Industry an update Available guidelines Industry practices Current challenges
More informationWHO GUIDELINE Stability testing of active pharmaceutical ingredients and finished pharmaceutical products
WHO GUIDELINE Stability testing of active pharmaceutical ingredients and finished pharmaceutical products 1. Introduction 1.1 Objectives of these guidelines 1.2 Scope of these guidelines 1.3 General principles
More informationAPI Stability Protocols and. Chris Byrne Tasmanian Alkaloids
API Stability Protocols and Evaluations Chris Byrne Tasmanian Alkaloids API Stability Overview APIs = 100% pure Limited (if any) degradation No interactions with other agents in drug products Less likelihood
More informationEUROPEAN COMMISSION Directorate General Health and Consumer Protection. SANCO/3030/99 rev.4 11/07/00
EUROPEAN COMMISSION Directorate General Health and Consumer Protection SANCO/3030/99 rev.4 11/07/00 Technical Material and Preparations: Guidance for generating and reporting methods of analysis in support
More informationGuidance for Industry
Guidance for Industry Bioanalytical Methods Validation for Human Studies DRAFT GUIDANCE This guidance document is being distributed for comment purposes only. Comments and suggestions regarding this draft
More informationUSP Chapter 823 USP 32 (old) vs. USP 35 (new)
USP Chapter 823 USP 32 (old) vs. USP 35 (new) Sally W. Schwarz, MS, BCNP Research Associate Professor of Radiology Washington University School of Medicine St. Louis, MO Why USP Chapter ? FDA has
More informationOMCL Network of the Council of Europe QUALITY ASSURANCE DOCUMENT
OMCL Network of the Council of Europe QUALITY ASSURANCE DOCUMENT PA/PH/OMCL (13) 113 2R Evaluation and Reporting of Results Core document Full document title and reference Evaluation and Reporting of Results
More informationValidation of a Dual Wavelength Size Exclusion HPLC Method with Improved Sensitivity to Detect Aggregates of a Monoclonal Antibody Biotherapeutic
Validation of a Dual Wavelength Size Exclusion HPLC Method with Improved Sensitivity to Detect Aggregates of a Monoclonal Antibody Biotherapeutic By J. Tompkins1, T. Spurgeon 1, R. Tobias 1, J. Anders1,
More informationGUIDELINE FOR THE STABILITY TESTING
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 GUIDELINE FOR THE STABILITY TESTING OF NON-PRESCRIPTION (OTC)
More informationLEGAL REQUIREMENTS FOR STABILITY
BY DR. A.V.PRABHU LEGAL REQUIREMENTS FOR STABILITY 21 CFR 211.166- STABILITY TESTING GMP To assess stability characteristics to determine storage conditions and expiration dates. Written stability program
More informationLifecycle Management of Process Analytical Technology Procedures
Lifecycle Management of Process Analytical Technology Procedures IFPAC 2015 Marta Lichtig Senior Scientist in New Testing Technologies, ACS Member Contents General Comparison : PV guide to NIR model development
More informationInstitute for Reference Materials and Measurements Community Reference Laboratory for Feed Additives
EUROPEAN COMMISSION JOINT RESEARCH CENTRE Institute for Reference Materials and Measurements Community Reference Laboratory for Feed Additives D08/FSQ/CVH/GS/D(2007) 18417 CRL Evaluation Report on the
More informationInternational Journal of ChemTech Research CODEN (USA): IJCRGG, ISSN: , ISSN(Online): Vol.10 No.6, pp , 2017
International Journal of ChemTech Research CODEN (USA): IJCRGG, ISSN: 0974-4290, ISSN(Online):2455-9555 Vol.10 No.6, pp 1073-1082, 2017 Cost Effective Stabilty Indicating Reverse Phase High Performance
More informationINTERNATIONAL RESEARCH JOURNAL OF PHARMACY
INTERNATIONAL RESEARCH JOURNAL OF PHARMACY www.irjponline.com ISSN 2230 8407 Research Article RP-HPLC METHOD DEVELOPMENT AND VALIDATION OF DOXAZOSIN FOR THE PRESENCE OF DEGRADATION PRODUCTS AND RELATED
More informationTHE DISSOLUTION PROCEDURE: DEVELOPMENT AND VALIDATION
THE DISSOLUTION PROCEDURE: DEVELOPMENT AND VALIDATION Pharmacopeial Forum Vol. 31(5)(Sept.-Oct. 2005) By : Mr. Seubpong Kumpusiri Mrs. Patima Maneesatid 26 May 2006 THE DISSOLUTION PROCEDURE: DEVELOPMENT
More informationDECISION TREE #1: ESTABLISHING ACCEPTANCE CRITERION FOR A SPECIFIED IMPURITY IN A NEW DRUG SUBSTANCE
DECISION TREE #1: ESTABLISHING ACCEPTANCE CRITERION FOR A SPECIFIED IMPURITY IN A NEW DRUG SUBSTANCE Determine impurity level in relevant batches 1 Determine mean + upper confidence limit for the impurity
More informationValidation of Thin Layer Chromatographic Procedures
Validation of Thin Layer Chromatographic Procedures International Symposium for High-Performance Thin-Layer Chromatography HPTLC 2011 July 7th, 2011, Basle Topics ICH Q2(R1) and nothing else? Other guidance
More informationLaboratory Developed Tests. William Castellani, MD Inter-regional Commissioner Clinical Pathologist, Penn State Hershey Medical Center
Laboratory Developed Tests William Castellani, MD Inter-regional Commissioner Clinical Pathologist, Penn State Hershey Medical Center Objectives Compare and contrast new test validation requirements for
More informationDraft regional guidelines on stability testing of active substances and pharmaceutical products
Regional Committee for the EM/RC53/12 Eastern Mediterranean August 2006 Fifty-third Session Original: Arabic Agenda item 17 Draft regional guidelines on stability testing of active substances and pharmaceutical
More informationPesticides: Method Validation and Quality Control
The guidance in 10684/2009 is intended for laboratories control or in the monitoring of pesticide residues in food involved in official and feed in the European Union. The document describes the method
More informationSTIMULI TO THE REVISION PROCESS. Bioassay Glossary
Vol. 32(4) [July Aug. 2006] of the USPC or the USP Council of Experts 1359 Bioassay Glossary Robert Singer, PDL Biopharma; David M. Lansky, Lansky Consulting; and Walter W. Hauck, Thomas Jefferson University
More informationAutomating EPA 6020 Compliant Analysis with the Agilent 7900 ICP-MS and ESI prepfast Autodilution System
Automating EPA 6020 Compliant Analysis with the Agilent 7900 ICP-MS and ESI prepfast Autodilution System Application Note Environmental Authors Austin Schultz and Jake Unnerstall, Elemental Scientific,
More information